Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Pak J Med Sci ; 39(3): 737-741, 2023.
Article in English | MEDLINE | ID: mdl-37250543

ABSTRACT

Background and Objective: Emotional distress experienced by patients with diabetes (PWD) can affect glycemic control and quality of life. However, limited tools are available in Indonesia to detect emotional distress in PWD in clinical setting or research. This study aimed to evaluate the validity and reliability of the Indonesia version of the Problem Areas in Diabetes (PAID-5) scale. Methods: After the cross-cultural adaptation method was conducted, psychometric tests were done from August to November 2019 at affiliated hospitals in Yogyakarta by involving 100 adult PWD. All PWD with no medical records of mental health problems or cognitive disorders were voluntarily included. Content and construct validity and internal consistency measurements were used to evaluate the psychometric properties. Results: The mean age was 61.2 years of the men and women who equally participated in the study and mostly were non-working patients. The PAID-5 resulted in five question items to identify the emotional distress of PWD in the Indonesian language. Some minor modifications were done in items four and five after discussing them with the original authors and experts in Indonesia. The results showed item content validity index for item and scale were 0.6-0.8 and 0.72, respectively. The calculated r-values ranged from 0.751 to 0.888, which were higher than the r table (0.197). The Cronbach alpha of the Indonesia version of PAID-5 was 0.87 with inter-item and item-total correlations of 0.43-0.71 and 0.61-0.79, respectively. Conclusion: The results of the study indicate that PAID-5 is considered valid and reliable to assess emotional distress among PWD and can be useful in clinical setting or for research purposes. Continued assessment of emotional distress is applicable and helps patients to better deal with their emotional distress.

2.
Int J Nurs Pract ; 27(6): e12999, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34427380

ABSTRACT

AIM: This study aimed to test the validity and reliability of a four-item patient health questionnaire as a psychological distress screening tool for patients with type 2 diabetes in Indonesia. METHODS: This cross-cultural adaptation study was applied in five public health-care centres in Indonesia in August-October 2018 using a four-item patient health questionnaire. The content, convergent and factorial validity were assessed, and Cronbach's alpha coefficient was the reliability indicator. RESULTS: A total of 147 participants were involved. Content validity resulted in acceptable outcomes (item and scale content validity indexes were 0.95 and 0.75, respectively). Anxiety and depression were associated with total score and psychological distress status (P < 0.001), supporting the convergent validity outcomes. Principal component analysis using varimax rotation revealed two factors, explaining 76.14% of variance (P < 0.001). Cronbach's alpha coefficients for anxiety, depression and total score were 0.780, 0.500 and 0.713, respectively. CONCLUSIONS: The study demonstrated adequate validity and reliability for the Indonesian version of a four-item patient health questionnaire among patients with type 2 diabetes. Therefore, it is applicable as a screening tool for psychological distress in this population.


Subject(s)
Diabetes Mellitus, Type 2 , Psychological Distress , Diabetes Mellitus, Type 2/diagnosis , Humans , Indonesia , Psychometrics , Reproducibility of Results , Surveys and Questionnaires
3.
Diabetes Metab Syndr ; 14(5): 1109-1120, 2020.
Article in English | MEDLINE | ID: mdl-32659694

ABSTRACT

BACKGROUND AND AIMS: The global pandemic of coronavirus (COVID-19) affects almost all countries in the world, which potentially alter diabetes management. Many diabetes patients are experiencing barrier of care due to the policy related to COVID-19. This article aims to review the current evidence on diabetes management and specific considerations during the COVID-19 pandemic for people living with diabetes. METHODS: We conducted a scoping review in PubMed, Science Direct, DOAJ and Microsoft Academics databases from January 1 to April 17, 2020. Searching terms included "COVID-19", "severe acute respiratory syndrome coronavirus 2", and "Diabetes Mellitus" were used. Only scientific articles discussing diabetes management and specific considerations were selected and extracted. RESULTS: A total of 7 articles was selected in the analysis. Most were published in diabetes journals (85.71%). All articles (100%) discussed diabetes management and 71.43% of them provided diabetes care in specific considerations. We discussed issue of diabetes management in glycemic control and monitoring, dietary intake, physical activity, medication, education and prevention of COVID-19 infection that applicable for diabetes patients. In addition, specific considerations explored caring for diabetes in children and adolescents, pregnancy, elderly, emergency or critical care, to offer certain concern for raising the awareness. CONCLUSIONS: This review specifies a summary of diabetes management as well as the particular considerations to care people living with diabetes during COVID-19 pandemic. Patients, health care providers, and policy makers could take advantage of the review to assist diabetic people passing through COVID-19 pandemic session with optimum glycemic outcome.


Subject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections/prevention & control , Diabetes Mellitus/drug therapy , Pandemics/prevention & control , Patient Education as Topic , Pneumonia, Viral/prevention & control , Telemedicine , COVID-19 , Coronavirus Infections/complications , Coronavirus Infections/transmission , Coronavirus Infections/virology , Diabetes Mellitus/virology , Disease Management , Humans , Pneumonia, Viral/complications , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , Prognosis , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL